McDavid Stilwell
No más puestos en curso
Fortuna: 145 339 $ al 30/04/2024
Historial de carrera de McDavid Stilwell
Antiguos cargos conocidos de McDavid Stilwell.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| COHERUS BIOSCIENCES, INC. | Director Financiero/CFO | 08/03/2021 | 08/12/2023 |
| Contacto de Relaciones con Inversores | 01/10/2020 | 08/03/2021 | |
| Public Communications Contact | 01/10/2020 | 08/03/2021 | |
| OREXIGEN THERAPEUTICS, INC. | Contacto de Relaciones con Inversores | 01/03/2012 | 01/11/2016 |
| Public Communications Contact | 01/03/2012 | 01/11/2016 | |
GTx, Inc.
 GTx, Inc. Pharmaceuticals: MajorHealth Technology GTx, Inc. is a a biopharmaceutical company, which engages in the discovery, development, and commercialization of small molecules for the treatment of muscle-related diseases and other serious medical conditions. It focuses on developing selective androgen receptor modulators and selective androgen receptor degrader for the treatment of breast cancer, stress urinary incontinence, Duchenne muscular dystrophy, and prostate cancer. The company was founded by Marc Steven Hanover and Mitchell Shuster Steiner on September 24, 1997 and is headquartered in Memphis, TN. | Public Communications Contact | 01/01/2005 | 01/01/2012 |
| SANGAMO THERAPEUTICS, INC. | Contacto de Relaciones con Inversores | 01/11/2016 | - |
| Public Communications Contact | 01/11/2016 | - |
Formación de McDavid Stilwell.
| St. John's College | Undergraduate Degree |
| Harvard Business School | Masters Business Admin |
Estadísticas
Internacional
| Estados Unidos | 7 |
Operativa
| Public Communications Contact | 4 |
| Investor Relations Contact | 3 |
| Undergraduate Degree | 1 |
Sectorial
| Health Technology | 5 |
| Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| SANGAMO THERAPEUTICS, INC. | Health Technology |
| COHERUS BIOSCIENCES, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Orexigen Therapeutics, Inc.
 Orexigen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Orexigen Therapeutics, Inc. is a biopharmaceutical company, which focuses on the development of pharmaceutical product candidates for the treatment of obesity. Its primary activities include recruiting personnel, conducting research and development, including clinical trials, raising capital, and preparing for the marketing and commercialization of its product, contrave. The company was founded by Eckard Weber in September 2002 and is headquartered in La Jolla, CA. | Health Technology |
GTx, Inc.
GTx, Inc. Pharmaceuticals: MajorHealth Technology GTx, Inc. is a a biopharmaceutical company, which engages in the discovery, development, and commercialization of small molecules for the treatment of muscle-related diseases and other serious medical conditions. It focuses on developing selective androgen receptor modulators and selective androgen receptor degrader for the treatment of breast cancer, stress urinary incontinence, Duchenne muscular dystrophy, and prostate cancer. The company was founded by Marc Steven Hanover and Mitchell Shuster Steiner on September 24, 1997 and is headquartered in Memphis, TN. | Health Technology |
- Bolsa de valores
- Insiders
- McDavid Stilwell
- Experiencia
